HUP0103265A2 - Proszapozineredetű ciklikus peptidek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
Proszapozineredetű ciklikus peptidek, azokat tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0103265A2 HUP0103265A2 HU0103265A HUP0103265A HUP0103265A2 HU P0103265 A2 HUP0103265 A2 HU P0103265A2 HU 0103265 A HU0103265 A HU 0103265A HU P0103265 A HUP0103265 A HU P0103265A HU P0103265 A2 HUP0103265 A2 HU P0103265A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- derived peptides
- prosaposin
- cyclic
- cyclic prosaposin
- Prior art date
Links
- 102100036197 Prosaposin Human genes 0.000 title 1
- 101710152403 Prosaposin Proteins 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835998P | 1998-08-28 | 1998-08-28 | |
| PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0103265A2 true HUP0103265A2 (hu) | 2002-02-28 |
| HUP0103265A3 HUP0103265A3 (en) | 2002-09-30 |
Family
ID=22268937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103265A HUP0103265A3 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1105420A1 (hu) |
| JP (2) | JP4528443B2 (hu) |
| KR (1) | KR20010079695A (hu) |
| CN (1) | CN1324367A (hu) |
| AU (1) | AU751034B2 (hu) |
| BR (1) | BR9913490A (hu) |
| CA (1) | CA2341810A1 (hu) |
| CZ (1) | CZ2001655A3 (hu) |
| HU (1) | HUP0103265A3 (hu) |
| IL (1) | IL141586A0 (hu) |
| PL (1) | PL204359B1 (hu) |
| WO (1) | WO2000012553A1 (hu) |
| ZA (1) | ZA200102489B (hu) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| WO2000012553A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
| AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
| IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| ES2641272T3 (es) | 2006-04-28 | 2017-11-08 | Children's Hospital Medical Center | Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana |
| WO2008051818A2 (en) * | 2006-10-20 | 2008-05-02 | Children's Hospital Medical Center | Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
| CN107530257B (zh) | 2015-04-23 | 2022-03-29 | 宝洁公司 | 表面活性剂可溶性去头皮屑剂的递送 |
| CN108697609A (zh) | 2016-03-03 | 2018-10-23 | 宝洁公司 | 气溶胶去头皮屑组合物 |
| WO2018075850A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Dosage of foam for delivering consumer desired dosage volume and surfactant amount in an optimal formulation space |
| CN109843382A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型 |
| US11154467B2 (en) | 2016-10-21 | 2021-10-26 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair conditioning benefits |
| CN109862941A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型 |
| WO2018075847A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
| MX2019003107A (es) | 2016-10-21 | 2019-09-13 | Procter & Gamble | Productos de champu compactos y estables con baja viscosidad y agente reductor de viscosidad. |
| US10888505B2 (en) | 2016-10-21 | 2021-01-12 | The Procter And Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
| US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
| US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
| US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
| MX2020003316A (es) | 2017-10-10 | 2021-12-06 | Procter & Gamble | Composición de champú compacto que contiene surfactantes libres de sulfato. |
| EP4108228A1 (en) | 2017-10-10 | 2022-12-28 | The Procter & Gamble Company | Sulfate free clear personal cleansing composition comprising low inorganic salt |
| MX2020003318A (es) | 2017-10-10 | 2021-12-06 | Procter & Gamble | Composición de champú compacta con surfactantes aniónicos a base de aminoácidos y polímeros catiónicos. |
| MX2020003315A (es) | 2017-10-10 | 2021-12-06 | Procter & Gamble | Método para tratar el cabello o la piel con una composición para el cuidado personal en forma de espuma. |
| JP7280265B2 (ja) | 2017-12-20 | 2023-05-23 | ザ プロクター アンド ギャンブル カンパニー | シリコーンポリマーを含有する透明なシャンプー組成物 |
| EP3813774A1 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Low surfactant aerosol antidandruff composition |
| US11980679B2 (en) | 2019-12-06 | 2024-05-14 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
| WO2021173203A1 (en) | 2020-02-27 | 2021-09-02 | The Procter & Gamble Company | Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics |
| US11819474B2 (en) | 2020-12-04 | 2023-11-21 | The Procter & Gamble Company | Hair care compositions comprising malodor reduction materials |
| US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
| US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| WO2000012553A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
-
1999
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Application Discontinuation
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR9913490A (pt) | 2001-09-25 |
| PL204359B1 (pl) | 2010-01-29 |
| IL141586A0 (en) | 2002-03-10 |
| JP2010150272A (ja) | 2010-07-08 |
| HUP0103265A3 (en) | 2002-09-30 |
| CA2341810A1 (en) | 2000-03-09 |
| JP4528443B2 (ja) | 2010-08-18 |
| WO2000012553A1 (en) | 2000-03-09 |
| ZA200102489B (en) | 2002-06-04 |
| PL346346A1 (en) | 2002-02-11 |
| JP2002523518A (ja) | 2002-07-30 |
| EP1105420A1 (en) | 2001-06-13 |
| AU751034B2 (en) | 2002-08-08 |
| CZ2001655A3 (cs) | 2001-11-14 |
| KR20010079695A (ko) | 2001-08-22 |
| CN1324367A (zh) | 2001-11-28 |
| AU5690599A (en) | 2000-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
| HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
| HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
| HUP0102372A3 (en) | Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same | |
| IL142531A0 (en) | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
| HUP0103793A3 (en) | N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them | |
| HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
| HUP0102579A3 (en) | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use | |
| HUP0003592A3 (en) | Lh-rh peptide analogues, their use and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
| NZ305735A (en) | Cyclic peptide antifungal agents, preparation and pharmaceutical compositions thereof | |
| HUP0102515A3 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them | |
| HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
| IL125908A0 (en) | Peptides and pharmaceutical compositions comprising same | |
| HUP0201696A2 (en) | Cyclic peptides, pharmaceutical compositions comprising thereof and their use |